Bay Street News, 2020

RP1: Registration-directed randomized controlled Phase 2 clinical trial of RP1 in combination with cemiplimab-rwlc (Libtayo®) in cutaneous squamous cell carcinoma […]

CANTON, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on […]

PLEASANTON, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) — Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider […]

FDA sets PDUFA date of June 26, 2020Acceptance follows December 26, 2019 NDA resubmissionNEEDHAM, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE) […]

MIDDLETOWN, R.I., Jan. 13, 2020 (GLOBE NEWSWIRE) — KVH Industries, Inc., (Nasdaq: KVHI), chief executive officer, Martin Kits van Heyningen, […]

— XPOVIO Unaudited Net Product Sales of between $17 and $18 Million for Fourth Quarter 2019 and between $30 and […]

CANTON, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE) — Destination XL Group, Inc. (NASDAQ:DXLG), the largest omni-channel specialty retailer of big and […]

CALGARY, Alberta, Jan. 13, 2020 (GLOBE NEWSWIRE) — Black Diamond Group Limited (“Black Diamond” or “the Company”) (TSX: BDI) announced […]

All amounts in U.S. dollars unless otherwise statedInvestment Overview:Proposal is being made at a BEP-to-TERP exchange ratio equivalent to 0.36, […]

OKLAHOMA CITY, Jan. 13, 2020 (GLOBE NEWSWIRE) — Chaparral Energy, Inc. (NYSE: CHAP) announced today that it has received notification […]